Coincidentally, a similar phenomenon was reported not long after the post-marketing of cinacalcet which is a calcimimetic compound used to suppress parathyroid hormone secretion from parathyroid glands in both primary hyperparathyroidism and secondary hyperparathyroidism. Here, PTH is linked to secondary hyperparathyroidism.